IndustryWeek : Abbott Opens New Biotechnology Manufacturing Facility In Puerto Rico

IndustryWeek : Abbott Opens New Biotechnology Manufacturing Facility In Puerto Rico: "In order to support the long-term supply of its biologic agent, HUMIRA (adalimumab), as well as future biologics, Abbott opened a new biologics manufacturing facility (ABL) in Puerto on April 10."